AAAAAA

   
Results: 1-25 | 26-40
Results: 1-25/40

Authors: HARTMANN K KUFFER M BALZARINI J NAESENS L GOLDBERG M ERFLE V GOEBEL FD DECLERCQ E JINDRICH J HOLY A BISCHOFBERGER N KRAFT W
Citation: K. Hartmann et al., EFFICACY OF THE ACYCLIC NUCLEOSIDE PHOSPHONATES (S)-9-(3-FLUORO-2-PHOSPHONYLMETHOXYPROPYL)ADENINE (FPMPA) AND 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE (PMEA) AGAINST FELINE IMMUNODEFICIENCY VIRUS, Journal of acquired immune deficiency syndromes and human retrovirology, 17(2), 1998, pp. 120-128

Authors: VANROMPAY KKA MARTHAS ML LIFSON JD BERARDI CJ VASQUEZ GM AGATEP E DEHQANZADA ZA CUNDY KC BISCHOFBERGER N PEDERSEN NC
Citation: Kka. Vanrompay et al., ADMINISTRATION OF 9-[2-(PHOSPHONOMETHOXY)PROPYL]ADENINE (PMPA) FOR PREVENTION OF PERINATAL SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION IN RHESUS MACAQUES, AIDS research and human retroviruses, 14(9), 1998, pp. 761-773

Authors: VANROMPAY KKA BERARDI CJ AGUIRRE NL BISCHOFBERGER N LIETMAN PS PEDERSEN NC MARTHAS ML
Citation: Kka. Vanrompay et al., 2 DOSES OF PMPA PROTECT NEWBORN MACAQUES AGAINST ORAL SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION, AIDS, 12(9), 1998, pp. 79-83

Authors: NAESENS L BISCHOFBERGER N AUGUSTIJNS P ANNAERT P VANDENMOOTER G ARIMILLI MN KIM CU DECLERCQ E
Citation: L. Naesens et al., ANTIRETROVIRAL EFFICACY AND PHARMACOKINETICS OF ORAL BIS(ISOPROPYLOXYCARBONYLOXYMETHYL) 9-(2-PHOSPHONYLMETHOXYPROPYL)ADENINE IN MICE, Antimicrobial agents and chemotherapy, 42(7), 1998, pp. 1568-1573

Authors: ROBBINS BL SRINIVAS RV KIM C BISCHOFBERGER N FRIDLAND A
Citation: Bl. Robbins et al., ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS ACTIVITY AND CELLULAR-METABOLISM OFA POTENTIAL PRODRUG OF THE ACYCLIC NUCLEOSIDE PHOSPHONATE 9-R-(2-PHOSPHONOMETHOXYPROPYL)ADENINE (PMPA), BIS(ISOPROPYLOXYMETHYLCARBONYL)PMPA, Antimicrobial agents and chemotherapy, 42(3), 1998, pp. 612-617

Authors: MENDEL DB TAI CY ESCARPE PA LI WX SIDWELL RW HUFFMAN JH SWEET C JAKEMAN KJ MERSON J LACY SA LEW W WILLIAMS MA ZHANG LJ CHEN MS BISCHOFBERGER N KIM CU
Citation: Db. Mendel et al., ORAL-ADMINISTRATION OF A PRODRUG OF THE INFLUENZA-VIRUS NEURAMINIDASEINHIBITOR GS-4071 PROTECTS MICE AND FERRETS AGAINST INFLUENZA INFECTION, Antimicrobial agents and chemotherapy, 42(3), 1998, pp. 640-646

Authors: LI WX ESCARPE PA EISENBERG EJ CUNDY KC SWEET C JAKEMAN KJ MERSON J LEW W WILLIAMS M ZHANG LJ KIM CU BISCHOFBERGER N CHEN MS MENDEL DB
Citation: Wx. Li et al., IDENTIFICATION OF GS-4104 AS AN ORALLY BIOAVAILABLE PRODRUG OF THE INFLUENZA-VIRUS NEURAMINIDASE INHIBITOR GS-4071, Antimicrobial agents and chemotherapy, 42(3), 1998, pp. 647-653

Authors: TSAI CC EMAU P FOLLIS KE BECK TW BENVENISTE RE BISCHOFBERGER N LIFSON JD MORTON WR
Citation: Cc. Tsai et al., EFFECTIVENESS OF POSTINOCULATION (R)-9-(2-PHOSPHONYLMETHOXYPROPYL) ADENINE TREATMENT FOR PREVENTION OF PERSISTENT SIMIAN IMMUNODEFICIENCY VIRUS SIVMNE INFECTION DEPENDS CRITICALLY ON TIMING OF INITIATION AND DURATION OF TREATMENT, Journal of virology, 72(5), 1998, pp. 4265-4273

Authors: HE GX WILLIAMS JP POSTICH MJ SWAMINATHAN S SHEA RG TERHORST T LAW VS MAO CT SUEOKA C COUTRE S BISCHOFBERGER N
Citation: Gx. He et al., IN-VITRO AND IN-VIVO ACTIVITIES OF OLIGODEOXYNUCLEOTIDE-BASED THROMBIN INHIBITORS CONTAINING NEUTRAL FORMACETAL LINKAGES, Journal of medicinal chemistry, 41(22), 1998, pp. 4224-4231

Authors: HE GX KRAWCZYK SH SWAMINATHAN S SHEA RG DOUGHERTY JP TERHORST T LAW VS GRIFFIN LC COUTRE S BISCHOFBERGER N
Citation: Gx. He et al., N-2-SUBSTITUTED AND C-8-SUBSTITUTED OLIGODEOXYNUCLEOTIDES WITH ENHANCED THROMBIN INHIBITORY ACTIVITY IN-VITRO AND IN-VIVO, Journal of medicinal chemistry, 41(13), 1998, pp. 2234-2242

Authors: ARIMILLI MN KIM CU DOUGHERTY J MULATO A OLIYAI R SHAW JP CUNDY KC BISCHOFBERGER N
Citation: Mn. Arimilli et al., SYNTHESIS, IN-VITRO BIOLOGICAL EVALUATION AND ORAL BIOAVAILABILITY OF9-[2-(PHOSPHONOMETHOXY)PROPYL]ADENINE (PMPA) PRODRUGS, Antiviral chemistry & chemotherapy, 8(6), 1997, pp. 557-564

Authors: BARNARD DL BISCHOFBERGER N KIM CU HUFFMAN JH SIDWELL RW DOUGHERTY JR LEW W WILLIAMS MA YANG W
Citation: Dl. Barnard et al., ACYCLIC PHOSPHONOMETHYLETHER NUCLEOSIDE INHIBITORS OF RESPIRATORY VIRUSES, Antiviral chemistry & chemotherapy, 8(3), 1997, pp. 223-233

Authors: TSAI CC FOLLIS KE BECK TW SABO A BISCHOFBERGER N DAILEY PJ
Citation: Cc. Tsai et al., EFFECTS OF (R)-9-(2-PHOSPHONYLMETHOXYPROPYL) ADENINE MONOTHERAPY ON CHRONIC SIV INFECTION IN MACAQUES, AIDS research and human retroviruses, 13(8), 1997, pp. 707-712

Authors: HE GX BISCHOFBERGER N
Citation: Gx. He et N. Bischofberger, SELECTIVE 5'-O-ACETYLATION OF 2'-DEOXYNUCLEOSIDES AND NUCLEOSIDES BY A MODIFIED MITSUNOBU PROCEDURE, Nucleosides & nucleotides, 16(3), 1997, pp. 257-263

Authors: HE GX BISCHOFBERGER N
Citation: Gx. He et N. Bischofberger, PREPARATION OF FORMACETAL-LINKED PURINE-PURINE DINUCLEOTIDE ANALOGS, Tetrahedron letters, 38(6), 1997, pp. 945-948

Authors: NOWAK MA LLOYD AL VASQUEZ GM WILTROUT TA WAHL LM BISCHOFBERGER N WILLIAMS J KINTER A FAUCI AS HIRSCH VM LIFSON JD
Citation: Ma. Nowak et al., VIRAL DYNAMICS OF PRIMARY VIREMIA AND ANTIRETROVIRAL THERAPY IN SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION, Journal of virology, 71(10), 1997, pp. 7518-7525

Authors: KIM CU LEW W WILLIAMS MA LIU HT ZHANG LJ SWAMINATHAN S BISCHOFBERGER N CHEN MS MENDEL DB TAI CY LAVER WG STEVENS RC
Citation: Cu. Kim et al., INFLUENZA NEURAMINIDASE INHIBITORS POSSESSING A NOVEL HYDROPHOBIC INTERACTION IN THE ENZYME ACTIVE-SITE - DESIGN, SYNTHESIS, AND STRUCTURAL-ANALYSIS OF CARBOCYCLIC SIALIC-ACID ANALOGS WITH POTENT ANTIINFLUENZAACTIVITY, Journal of the American Chemical Society, 119(4), 1997, pp. 681-690

Authors: ALLEN SJW KRAWCZYK SH MCGEE LR BISCHOFBERGER N MULATO AS CHERRINGTON JM
Citation: Sjw. Allen et al., INHIBITION OF HIV-1 RNASE-H ACTIVITY BY NUCLEOTIDE DIMERS AND MONOMERS, Antiviral chemistry & chemotherapy, 7(1), 1996, pp. 37-45

Authors: DUNWIDDIE TV ABBRACCHIO MP BISCHOFBERGER N BRUNDEGE JM BUELL G COLLO G CORSI C DIAO L KAWASHIMA E JACOBSON KA LATINI S LIN RCS NORTH RA PAZZAGLI M PEDATA F PEPEU GC PROCTOR WR RASSENDREN F SURPRENANT A CATTABENI F
Citation: Tv. Dunwiddie et al., PURINOCEPTORS IN THE CENTRAL-NERVOUS-SYSTEM, Drug development research, 39(3-4), 1996, pp. 361-370

Authors: VANROMPAY KKA CHERRINGTON JM MARTHAS ML BERARDI CJ MULATO AS SPINNER A TARARA RP CANFIELD DR TELM S BISCHOFBERGER N PEDERSEN NC
Citation: Kka. Vanrompay et al., 9-[2-(PHOSPHONOMETHOXY)PROPYL]ADENINE THERAPY OF ESTABLISHED SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION IN INFANT RHESUS MACAQUES, Antimicrobial agents and chemotherapy, 40(11), 1996, pp. 2586-2591

Authors: NAESENS L BALZARINI J BISCHOFBERGER N DECLERCQ E
Citation: L. Naesens et al., ANTIRETROVIRAL ACTIVITY AND PHARMACOKINETICS IN MICE OF ORAL LOYLOXMETHYL)-9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE, THE BIS(PIVALOYLOXYMETHYL) ESTER PRODRUG OF 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE, Antimicrobial agents and chemotherapy, 40(1), 1996, pp. 22-28

Authors: KIM CU MCGEE LR KRAWCZYK SH HARWOOD E HARADA Y SWAMINATHAN S BISCHOFBERGER N CHEN MS CHERRINGTON JM XIONG SF GRIFFIN L CUNDY KC LEE A YU B GULNIK S ERICKSON JW
Citation: Cu. Kim et al., NEW SERIES OF POTENT, ORALLY BIOAVAILABLE, NONPEPTIDIC CYCLIC SULFONES AS HIV-1 PROTEASE INHIBITORS, Journal of medicinal chemistry, 39(18), 1996, pp. 3431-3434

Authors: TSAI CC FOLLIS KE SABO A GRANT R BISCHOFBERGER N
Citation: Cc. Tsai et al., EFFICACY OF 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE TREATMENT AGAINST CHRONIC SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION IN MACAQUES (VOL 171, PG 1338, 1995), The Journal of infectious diseases, 173(1), 1996, pp. 277-277

Authors: VONLUBITZ DKJE LIN RCS PAUL IA BEENHAKKER M BOYD M BISCHOFBERGER N JACOBSON KA
Citation: Dkje. Vonlubitz et al., POSTISCHEMIC ADMINISTRATION OF ADENOSINE AMINE CONGENER (ADAC) - ANALYSIS OF RECOVERY IN GERBILS, European journal of pharmacology, 316(2-3), 1996, pp. 171-179

Authors: VONLUBITZ DKJE BEENHAKKER M LIN RCS CARTER MF PAUL IA BISCHOFBERGER N JACOBSON KA
Citation: Dkje. Vonlubitz et al., REDUCTION OF POSTISCHEMIC BRAIN-DAMAGE AND MEMORY DEFICITS FOLLOWING TREATMENT WITH THE SELECTIVE ADENOSINE A(1) RECEPTOR A AGONIST, European journal of pharmacology, 302(1-3), 1996, pp. 43-48
Risultati: 1-25 | 26-40